Related Issuers
by Stephen Carter
Jul 07, 2020 12:52 PM ET
+++Corrects Moody's rating to B3 (not B2)+++
Avantor Funding Inc (AVTR) approx USD2bn (up from USD1.452bn) 144A/Reg S sr notes 2-part. B3/B-/BB (positive/positive/stable). Via GS/Citi/Barc/JPM/BofA joint books, PNC, HSBC, Jefferies as co-managers. No reg rights.
- USD1.550bn (up from USD1bn) due 2028 (8y). NC3 (MWC T+50bp) (par + 50% of coupon). Equity claw: 3y 40%. IPT: 5.00%-5.25%. Px talk: 4.75%-5.00%. Launched: $1.55bn at 4.625%.
- EUR400m due 2028 (8y). NC3 (MWC B+50bp) (par +50% of coupon). Equity claw: 3y 40%. IPT 4.00%-4.25%. Px talk: 4% area. Launched: EUR400m at 3.875%.
Did investor call at 2pm UKT, 9am NYT today. Books closed at 12pm NYT/5pm UKT today. Reconfirms due at 1pm NYT/ 6pm UKT today. Pricing today NY afternoon. UOP: along with $140m cash on hand to redeem a portion (USD1.452bn) of its USD2bn 9% sr notes due 10/01/25 (MWC T+50bp). Also increasing and extending its revolver from $250m due Nov 2022 to $515m due July 2025. Biz: a global provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries, HQ: Radnor, PA.